Nirmatrelvir-ritonavir use among adults hospitalized with COVID-19 during the Omicron phase of the COVID-19 pandemic, Canadian Nosocomial Infection Surveillance Program

• Published in: Canada communicable disease report Vol. 49; no. 7-8; pp. 351 - 357
• Main Authors: Mitchell, Robyn, Lee, Diane, Pelude, Linda, Comeau, Jeannette, Conly, John, Ellis, Chelsey, Ellison, Jennifer, Embil, John, Evans, Gerald, Johnston, Lynn, Johnstone, Jennie, Katz, Kevin, Kibsey, Pamela, Lee, Bonita, Lefebvre, Marie-Astrid, Longtin, Yves, McGeer, Allison, Mertz, Dominik, Minion, Jessica, Smith, Stephanie, Srigley, Jocelyn, Suh, Kathryn, Tomlinson, Jen, Wong, Alice, Thampi, Nisha, Frenette, Charles
• Format: Journal Article
• Language: English
• Published: Canada Public Health Agency of Canada 01.08.2023
• Series: Enteric Diseases: A Major Health Problem in Canada
• Subjects: Surveillance; COVID-19; hospitalized patients; nirmatrelvir-ritonavir; Omicron

Recent studies have demonstrated the effectiveness of nirmatrelvir-ritonavir in reducing the risk of progression to severe disease among outpatients with mild to moderate coronavirus disease 2019 (COVID-19); however, data are limited regarding the use and role of nirmatrelvir-ritonavir among hospita...